Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/14/2003EP1041996A4 Keratinocyte growth factor-2 formulations
05/14/2003EP1036095A4 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
05/14/2003EP0991946B1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0868427B1 Methods for identifying compounds that bind to a target
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003EP0772633B1 Complexes for use in the diagnosis of vascular diseases
05/14/2003EP0672141B1 Methods of preparing soluble, oligomeric proteins
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418251A Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
05/14/2003CN1418223A Novel human hepatoma associated protein and coding sequence thereof
05/14/2003CN1418106A 疫苗 Vaccine
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1417587A Application of 334´¢×360 peptide segment of human ZP3
05/14/2003CN1417340A Expression of human interleukin-12 in craze noctuid and its purifying process
05/14/2003CN1417331A Biological steel gene and its encoded protein
05/14/2003CN1417330A Meltiple antigenic compound Bt gene and its application in plant
05/14/2003CN1417231A Prepn of recombinant human parathyroid hormone PTH (1-34)
05/14/2003CN1417230A Prepn of Scorpion venom polypeptide
05/14/2003CN1417229A Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition
05/14/2003CN1417228A Fluorescent phycocyanin and fluorescent phycoerythrin and their application
05/14/2003CN1417227A Process of preparing strong fluorescent phycocyanin
05/14/2003CN1417226A Method of separating, purifying and recombining thioredoxin fusion protein from colibacillus and uts application
05/14/2003CN1417222A Biological steel gene and its encoded protein
05/14/2003CN1417221A Biological steel gene and its encoded protein
05/14/2003CN1108309C Process for purifying nerve growth factor from venin
05/13/2003US6564152 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists
05/13/2003US6564151 Assigning protein functions by comparative genome analysis protein phylogenetic profiles
05/13/2003US6564114 Intensity data, computer
05/13/2003US6563023 Nucleotide sequences coding preferential polypeptide; for use as tool in genetic engineering
05/13/2003US6563021 Production of cotton fiber with improved fiber characteristics
05/13/2003US6563019 Genetically engineering disease and stress resistant plants; obtain cells, incubate with vector contain iron binding protein, transform cells, recover transformed cells, express vector, monitor and evaluate cell activity
05/13/2003US6563016 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
05/13/2003US6563015 Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
05/13/2003US6563014 Self-contained system for sustained viral replication
05/13/2003US6562958 Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections
05/13/2003US6562957 Genomic sequence encoding endoglin and fragments thereof
05/13/2003US6562951 Method of solubilization and naturation of somatotropins
05/13/2003US6562949 Antibody for use in the treatment of inflammation and inflammatory ddisorders
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562947 Guanosine diphosphate activation protein; for use in the of genetic disorders and cancer
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562945 Galanin receptor
05/13/2003US6562943 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
05/13/2003US6562942 Peptide for use in the prevention and treatment of diabetes
05/13/2003US6562800 Use of immunopotentiating sequences for inducing immune response
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562797 Methods and compositions for regulating FAS-associated apoptosis
05/13/2003US6562788 Novel class of peptide inhibitors of topoisomerase II chemotherapeutic antitumor agents
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562786 Compounds and methods for modulating apoptosis
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562632 Reactive dye for use as diagnostic tool in the analysis of biological systems
05/13/2003US6562617 Library of fusion nucleic acids for use as diagnostic tools in genetic engineering
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562605 Extraction of water soluble biopolymers from a fluid; form carbon dioxide/surfactant mixture, mix with water soluble biopolymer, recover biopolymer from mixture
05/13/2003US6562598 Factor X deletion mutants and analogues thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562595 Nucleic acids; fungicides
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562592 Nucleotide sequencs coding membrane protein for use in the treatment and prevention of bone, cardiovascular, cancer or central nervous system disorders
05/13/2003US6562591 Cell cycle protein for use in the diagnosis and tratment of cancer and cell proliferative disorders
05/13/2003US6562590 Controlling biological pests; generate genetically engineered microorganism, expose to insect pests, monitor effect on insect propagation
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562582 Removing preferential microorganism from sample; obtain sample, incubate with prophylactic agent, monitor sample for presence of microorganism
05/13/2003US6562580 Detection of preferential binding protein; obtain kinase protein, incubate with potential binding protein, monitor activity of kinase, adjustment in activity indicates bound protein
05/13/2003US6562579 Diagnosing autoimmune disease; obtain sample, incubate with antibody, determine the concentration of preferential cytokine protein in sample, comparing to control, adjustment in cytokine concentration indicates autoimmune disease
05/13/2003US6562578 IL-17-like cytokine binding compounds and antibodies
05/13/2003US6562563 Detection of modulator of mitochondrial permeability transition; obtain cell containing mitochondrion, incubate with modulator, exposing cell to excitation energy, detect energy transfer, compare to control
05/13/2003US6562376 DNA vaccines against poxviruses
05/13/2003US6562351 Fusion proteins; genetic engineering
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562347 Eliciting immune response for cancer treatment or human immunodeficiency virus infection prevention or treatment
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562344 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562334 Canine interleukin 12 administration as an immune disease treatment
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003CA2411750A1 Oligopeptides for promoting hair growth
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/08/2003WO2003038724A2 Methods and apparatus for protein sequence analysis
05/08/2003WO2003038441A2 Screening methods based on cited family proteins
05/08/2003WO2003038435A1 Method of analysing the conformation of a peptide having an affinity for target substances and the use thereof in the analysis of lipoproteins
05/08/2003WO2003038434A2 Serological assay for neospora caninum
05/08/2003WO2003038402A2 A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
05/08/2003WO2003038118A1 Method of evaluating phosphatase inhibitors
05/08/2003WO2003038116A2 Salmonella virulence factors and uses thereof
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038112A2 A composition and method to alter lean body mass and bone properties in a subject
05/08/2003WO2003038101A1 Gene expression
1 ... 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 ... 2916